These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 764844)

  • 1. Reduced lethality in mice receiving a combined dose of cyclophosphamide and busulphan.
    Millar JL; Hudspith BN; Blackett NM
    Br J Cancer; 1975 Aug; 32(2):193-8. PubMed ID: 764844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between granulocytic and erythroid repopulating ability.
    Constable TB; Blackett NM
    Exp Hematol; 1974; 2(3):131-7. PubMed ID: 4616841
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of various cytotoxic agents on bone marrow progenitor cells as measured by diffusion chamber assays.
    Squires DJ; Lamerton LF
    Br J Haematol; 1975 Jan; 29(1):31-42. PubMed ID: 1201202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of destruction and regeneration of the haemopoietic system after administration of busulphan and cyclophosphamide followed by bone marrow transplantation. Peripheral blood parameters.
    Szczylik C; Ratajczak MZ; Urbanowska E; Jedrzejczak WW
    Acta Med Pol; 1989; 30(3-4):93-109. PubMed ID: 2519630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The granulopoietic effect of human urinary colony stimulating factor on normal and cyclophosphamide treated mice.
    Yanai N; Yamada M; Watanabe Y; Saito M; Kuboyama M; Motoyoshi K; Takaku F; Funakoshi S; Watanabe M
    Exp Hematol; 1983 Nov; 11(10):1027-36. PubMed ID: 6607174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation.
    Neidhart J; Mangalik A; Kohler W; Stidley C; Saiki J; Duncan P; Souza L; Downing M
    J Clin Oncol; 1989 Nov; 7(11):1685-92. PubMed ID: 2478670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactoferrin accelerates reconstitution of the humoral and cellular immune response during chemotherapy-induced immunosuppression and bone marrow transplant in mice.
    Artym J; Zimecki M; Kuryszko J; Kruzel ML
    Stem Cells Dev; 2005 Oct; 14(5):548-55. PubMed ID: 16305339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of granulocytic colony formation in agar diffusion chambers implanted in cyclophosphamide pretreated mice.
    Gordon MY; Blackett NM
    Br J Cancer; 1975 Jul; 32(1):51-9. PubMed ID: 1080672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth of human hematopoietic cells in immunodeficient mice conditioned with cyclophosphamide and busulfan.
    Basch RS; Quito FL; Beh J; Hirst JA
    Stem Cells; 1997; 15(4):314-23. PubMed ID: 9253116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A direct assay of granulocytic repopulating ability.
    Marsh JC; Blackett NM
    Exp Hematol; 1978 Feb; 6(2):135-40. PubMed ID: 342262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinations of cytotoxic agents that have less than expected toxicity on normal tissues in mice.
    Millar JL; McElwain TJ
    Antibiot Chemother (1971); 1978; 23():271-82. PubMed ID: 646327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sparing effect of cyclophosphamide (NSC-26271) pretreatment on animals lethally treated with gamma-irradiation.
    Millar JL; Hudspith BN
    Cancer Treat Rep; 1976 Apr; 60(4):409-14. PubMed ID: 1277215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulopoietic effects of colony-stimulating factor obtained from urine of patients with aplastic anemia on normal and cyclophosphamide-treated mice.
    Ishida Y; Azuno Y; Tanaka H; Tanaka M; Miyamura S; Kaneko T; Matsumoto N
    Acta Haematol; 1988; 80(1):1-7. PubMed ID: 3135686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weakening of genetic resistance. II. The effect of injection of the macrophage toxic agents silica and carragheenan and the cytostatic drugs cyclophosphamide, busulphan and vinblastin.
    Buurman WA; van Bruggen I
    Exp Hematol; 1976 Nov; 4(6):382-92. PubMed ID: 186293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of D-glucuronic acid on the regenerative processes of granulomonocytopoiesis in cytostatic-induced myelodepression].
    Gol'dberg ED; Dygaĭ AM; Karpova GV; Simanina EV; Khlusov IA; Shakhov VP; Agafonov VI
    Eksp Klin Farmakol; 1993; 56(6):25-8. PubMed ID: 8111290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy and radiation sensitivity.
    O'Grady LF; Lewis JP
    Exp Hematol; 1973; 1(4):215-21. PubMed ID: 4608636
    [No Abstract]   [Full Text] [Related]  

  • 17. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
    Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
    Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of myleran on murine hemopoiesis. I. Granulocytic cell line specificity of action on progenitor cells.
    Delmonte L
    Cell Tissue Kinet; 1978 Jul; 11(4):347-58. PubMed ID: 308393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium effects on granulopoiesis in mice following cytotoxic chemotherapy.
    Joyce RA; Chervenick PA
    Adv Exp Med Biol; 1980; 127():145-54. PubMed ID: 6967679
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
    Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
    Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.